Fragmentation-Related Phosphinylations Using 2-Aryl-2-phosphabicyclo[2.2.2]oct-5-ene- and -octa-5,7-diene 2-Oxides 449
(dd, 2 JPH
=
3 JHH = 12.8, C6–H), 6.89 (dd, 3 JPH = 34.6,
in chloroform) to give 14.3 g (68%) of dichlorocar-
bene adduct 2a-1 as an oil. 31P NMR (CDCl3) δ 76.3;
13C NMR (CDCl3) δ 21.1 (C4 –Me), 21.3 (3 J = 3.0, C1–
Me), 30.7 (1 J = 68.1, C4), 35.9 (2 J = 7.3, C1), 36.4
(2 J = 5.5, C5), 36.8 (1 J = 67.9, C2), 73.2 (3 J = 14.3, C6),
126.4 (1 J = 90.0, C1 ), 129.1 (2 J = 11.7, C2 ),∗ 130.0
(3 J = 9.7, C3 ),∗ 142.6 (C4 ), ∗may be reversed; 1H NMR
(CDCl3) δ 1.75 (s, C1–Me), 2.41 (s, Ar–Me); ES–MS,
289 (M + H); (M + H)+found = 289.0279, C13H15Cl2OP
requires 289.0316 for the 35Cl isotopomer.
3 JHH = 12.8, C5–H).
3Ba: 31P NMR (CDCl3) δ 15.3; 13C NMR (CDCl3)
δ
21.6 (C4 –Me), 25.0 (3 J = 12.7, C5–Me), 30.7
(1 J = 71.5, C2), 119.1 (1 J = 97.2, C6), 122.9 (2 J = 10.8,
C3), 129.4 (2 J = 13.1, C2 ),∗ 130.9 (3 J = 9.5, C3 ),∗ 142.7
(C4 ), 149.8 (C5), ∗may be reversed; 1H NMR (CDCl3)
δ 2.22 (s, C5–Me), 2.42 (Ar–Me), 6.29 (dt, C3–H).
3- and 5-Methyl-4-chloro-1-(2-methylphenyl-)-
1,2-dihydrophosphinine 1-Oxide 3Ab and 3Bb
6,6-Dichloro-1-methyl-3-(2-methylphenyl-)3-
phosphabicyclo[3.1.0]hexane 3-Oxide (2b)
Compounds 3Ab and 3Bb were prepared similarly
by heating 0.50 g (1.73 mmol) of the isomeric mix-
ture of dichlorocarbene adduct 2b at 135◦C for ca. 6
min. Yield: 0.31 g (70%) oil; ES–MS, 253 (M + H);
M+found = 253.0505, C13H14ClOP requires 253.0549
for the 35Cl isotopomer.
Compound 2b was prepared similarly using di-
hydrophosphole oxide 1b instead of 1a to fur-
nish a 8:2 mixture of isomers 2b-1 and 2b-
2. Yield: 13.1 g (66%); 2b-1 could be sepa-
rated as a crystalline compound by a simple
filtration, mp 125–127◦C (acetone); ES–MS, 289
(M + H); (M + H)+found = 289.0276, C13H15Cl2OP re-
quires 289.0316 for the 35Cl isotopomer.
3Ab: 31P NMR (CDCl3) δ 16.2; 13C NMR (CDCl3)
δ 20.5 (3 J = 3.3, C2 –Me), 22.3 (3 J = 8.7, C3–Me), 34.6
(1 J = 70.5, C2), 118.4 (1 J = 93.3, C6), 122.6 (2 J = 19.7,
C3), 124.8 (3 J = 12.0, C3 ),∗ 129.3 (1 J = 105.1, C1 ),
130.5 (3 J = 9.4, C4), 130.8 (3 J = 11.0, C5 ),∗ 131.1
(2 J = 10.6, C6 ),∗ 131.3 (C4 ), 139.8 (2 J = 10.0, C2 ),
2b-1: 31P NMR (CDCl3) δ 80.3; 13C NMR
(CDCl3) δ 21.2 (3 J = 3.5, C2 –Me), 21.4 (3 J = 5.2, C1–
Me), 30.1 (1 J = 68.3, C4), 35.6 (2 J = 7.5, C1), 36.1
(2 J = 6.0, C5), 36.2 (1 J = 68.3, C2), 72.1 (3 J = 11.5,
C6), 125.1 (3 J = 11.7, C5 ),∗ 129.8 (3 J = 11.7, C3 ),∗
130.2 (1 J = 93.3, C1 ) 131.0 (2 J = 9.9, C6 ),∗ 131.6 (C4 ),
140.5 (2 J = 7.4, C2 ), ∗tentative assignment; 1H NMR
(CDCl3) δ 1.76 (s, C1–Me), 2.67 (s, Ar–Me).
∗
1
142.4 (C5) tentative assignment; H NMR (CDCl3)
2
δ 2.10 (s, C3–Me), 2.50 (s, Ar–Me), 6.28 (dd, JPH
=
3 JHH = 12.3, C6–H), 6.91 (dd, 3 JPH = 34.9, 3 JHH = 12.8,
C5–H).
3Bb: 31P NMR (CDCl3) δ 15.7; 13C NMR (CDCl3) δ
20.5 (3 J = 3.3, C2 –Me), 24.0 (3 J = 13.0, C5–Me), 28.8
(1 J = 70.7, C2), 117.8 (1 J = 96.8, C6), 122.6 (2 J = 11.1,
C3), 124.7 (3 J = 12.0, C3 ),∗ 129.3 (1 J = 105.1, C1 ),
2b-2: 31P NMR (CDCl3) δ 78.2; 13C NMR
(CDCl3) δ 21.0 (3 J = 6.2, C1–Me), 21.6 (3 J = 3.7, C2 –
Me), 27.8 (1 J = 68.5, C4), 32.7 (2 J = 11.7, C1), 34.1
(1 J = 67.0, C2), 34.3 (2 J = 9.7, C5), 72.4 (3 J = 14.3, C6),
125.5 (3 J = 11.4, C5 ),∗ 130.2 (1 J = 86.2, C1 ), 131.3
(3 J = 10.9, C3 ),∗ 131.9 (C4 ), 132.0 (3 J = 9.5, C6 ),∗
141.3 (2 J = 7.9, C2 ), ∗tentative assignment.
130.8 (3 J = 11.0, C5 ),∗ 131.1 (2 J = 10.6, C6 ), 131.2
∗
(C4 ), 139.9 (2 J = 11.2, C2 ), 148.0 (C5) tentative as-
∗
1
signment; H NMR (CDCl3) δ 2.24 (s, C5–Me), 2.52
(Ar–Me), 6.32 (dt, C3–H).
General Procedure for the Synthesis
of Cycloadducts 4a, 4b, and 5
3- and 5-Methyl-4-chloro-1-(4-methylphenyl-)-
1,2-dihydrophosphinine 1-Oxide 3Aa and 3Ba
A
solution of 1.0 g (3.96 mmol) of tolyl-
dihydrophosphinine oxide 3a or 3b consisting of
∼75% of the A isomer and ∼25% of the B isomer and
4.8 mmol of N-phenylmaleimide (0.84 g) or dimethy-
lacetylene dicarboxylate (0.59 ml) in 25 ml of toluene
was stirred at the boiling point for 5 days. Solvent
was evaporated and the residue so obtained purified
by column chromatography (silica gel, 3% methanol
in chloroform) to furnish cycloadducts 4a, 4b, and 5
as the mixture of isomers. The data are listed below.
A 2.0 g (6.92 mmol) sample of 2a was heated at
138◦C in a vial until the evolution of hydrochlo-
ric acid ceased (ca. 7 min). The crude prod-
uct was purified by column chromatography (as
above) to provide 1.2 g (67%) of oily 3a as a
3:1 mixture of isomers A and B; ES–MS, 253
(M + H); (M + H)+found = 253.0507, C13H14ClOP re-
quires 253.0549 for the 35Cl isotopomer.
3Aa: 31P NMR (CDCl3) δ 16.4; 13C NMR (CDCl3) δ
21.6 (C4 –Me), 23.4 (3 J = 8.5, C3–Me), 36.6 (1 J = 71.4,
C2), 119.5 (1 J = 93.8, C6), 123.8 (2 J = 19.8, C3),
129.5 (2 J = 12.4, C2 ),∗ 130.6 (3 J = 10.6, C3 ),∗ 142.8
(4 J = 2.8, C4 ), 144.1 (C5), ∗may be reversed; 1H NMR
(CDCl3) δ 2.07 (s, C3–Me), 2.42 (s, Ar–Me), 6.18
1- and 11-Methyl-10-chloro-4-phenyl-8-p-tolyl-4-
aza-8ꢀ5 -phosphatricyclo[5.2.2.02,6]undec-10-ene-3,5-
dione 8-Oxide (4Aa and 4Ba) [18]. Yield: 1.0 g
(61%) of 4a as a 6:4 mixture of isomers A
and B; mp 132–134◦C (acetone); ES–MS, 426